Mitochondrial Injection in Human Eyes Offers New Hope for Vision Restoration
- For the first time, medical researchers have injected human mitochondria—the microscopic structures that generate cellular energy—directly into the eyes of a patient with severe vision loss, according to...
- Mitochondria are responsible for converting food and oxygen into usable energy for cellular function.
- To perform the intervention, doctors took a muscle biopsy from the patient's thigh and extracted tens of millions of fresh mitochondria.
For the first time, medical researchers have injected human mitochondria—the microscopic structures that generate cellular energy—directly into the eyes of a patient with severe vision loss, according to reporting by Science Alert. The experimental procedure was performed on a 26-year-old woman suffering from profound retinal damage following a severe brain hemorrhage. While the treatment did not restore her sight, the preliminary results demonstrated that the complex intervention produced no serious adverse side effects or dangerous immune responses, pointing toward potential safety for future investigations.
Cellular Energy and Retinal Damage
Mitochondria are responsible for converting food and oxygen into usable energy for cellular function. According to researchers cited in the coverage, retinal ganglion cells—which transmit visual data from the retina to the brain—rely heavily on this energy supply. When a patient experiences a prolonged interruption in blood and oxygen delivery, it can damage these cellular powerhouses and ultimately lead to cell death. In this case, the patient reached the hospital roughly 18 hours after suffering a severe brain hemorrhage. Emergency surgery saved her life, but the extended lack of oxygen severely harmed both optic nerves, leaving her nearly blind in both eyes. Subsequent brain and eye scans revealed distinct optic nerve atrophy within eight weeks. By the time treatment began roughly three months after the incident, her vision remained severely impaired, limited to light perception.
The Procedure and Physiological Responses
To perform the intervention, doctors took a muscle biopsy from the patient’s thigh and extracted tens of millions of fresh mitochondria. They then injected these freshly harvested cellular structures directly into the vitreous humor of both eyes. The objective was not to revive dead neural tissue, but rather to restore energy production in cells that remained alive. Measurements recorded following the procedure revealed temporary physiological shifts. In the 71 days leading up to the treatment, physicians tracked 45 pupillary light responses, none of which were normal. Just days after the injection, both pupils began showing occasional normal responses. Brain activity recordings also captured organized responses in the visual cortex during sessions held on days three, 44, and 45 post-treatment. These responses proved transient, with the left eye’s final normal reaction recorded on day 11 and sporadic responses continuing in the right eye until day 39.
Study Limitations and Next Steps
Researchers emphasize significant caveats regarding the findings, noting that the study involved only a single patient and lacked a control group. Furthermore, the team found no direct proof that the transplanted mitochondria actually entered the retinal ganglion cells, meaning the observed changes cannot be definitively attributed to the mitochondrial transfer alone. Because the improvements were temporary, investigators suggest that damaged cells might require repeated doses of healthy mitochondria to sustain any clinical benefit. The absence of severe side effects or dangerous immune reactions provides a baseline of safety, but further controlled trials are necessary to determine whether mitochondrial transplantation can become a viable therapeutic option for retinal damage.
